Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

10X_2W_E-coli

ABSTRACT: 10X_2W_E-coli

TISSUE(S): ['prostate']

SUBMITTER: Lin Li

PROVIDER: OEX00027312 | NODE | 2024-08-03

REPOSITORIES: NODE

ACCESS DATA

Json Xml

Similar Datasets

L1000 Dataset -small molecule perturbagens- LINCS Phase 1

Project description:Transcriptional profiles of cultured human cancer cell lines treated with small molecules: Expression of 978 representative genes is measured in 39 cell lines perturbed by 13 thousands of small molecules.

2014-05-30 | LDS-1191 | LINCS

L1000 Dataset -small molecule perturbagens- LINCS Trans-Center Project

Project description:Transcriptional profiles of cultured human breast and prostate cancer cell lines treated with small molecules: 6 cancer cell lines are treated with 6 small molecules, as a part of the LINCS Trans-Center Project. The expression level for 978 representative genes is measured.

2014-05-30 | LDS-1202 | LINCS

Tyrosine Kinase Inhibitor-induced cardiotoxicity in hiPSC derived cardiomyocytes - pilot dataset (qPCR validation)

Project description: Not available

2018-03-20 | LDS-1517 | LINCS

L1000 Consensus Signatures - CRISPR perturbagens

Project description: Not available

| LDS-1586 | LINCS

L1000 Consensus Signatures - shRNA perturbagens

Project description: Not available

| LDS-1585 | LINCS

Random-primed mRNA-sequencing transcriptomic dataset for 70 primary human cardiomyocyte cell samples

Project description:Each of 70 cell samples either at the control condition or treated with FDA-approved cancer drugs is sequenced by the single-ended random-primed mRNA-sequencing method with a read length of 100 base pairs, and a total of 70 raw sequence data files in the FASTQ format are generated. These sequence data files are then analyzed by a high-performance computational pipeline and ranked lists of gene signatures and biological processes related to drug-induced cardiotoxicity are generated for each drug. The raw sequence datasets and the analysis results have been carefully controlled for data quality, and they are made publicly available at the Gene Expression Omnibus (GEO) database repository of NIH. As such, this broad drug-stimulated transcriptomi dataset is valuable for the prediction of drug toxicities and their mitigations.

2020-11-09 | LDS-1587 | LINCS

3'-DGE mRNA-sequencing transcriptomic dataset for 914 primary human cardiomyocyte cell samples

Project description:Each of 914 cell samples either at the control condition or treated with FDA-approved cancer drugs is sequenced by the single-ended 3'-DGE mRNA-sequencing method with a read length of 46 base pairs, and a total of 914 raw sequence data files in the FASTQ format are generated. These sequence data files are then analyzed by a high-performance computational pipeline and ranked lists of gene signatures and biological processes related to drug-induced cardiotoxicity are generated for each drug. The raw sequence datasets and the analysis results have been carefully controlled for data quality, and they are made publicly available at the Gene Expression Omnibus (GEO) database repository of NIH. As such, this broad drug-stimulated transcriptomi dataset is valuable for the prediction of drug toxicities and their mitigations.

2020-11-09 | LDS-1592 | LINCS

diMN (Exp 3) - ALS and Control (unaffected) diMN cell lines differentiated from iPS cell lines using a short and direct differeintiation protocol - RNA-seq

Project description:Total RNA-Seq was carried out on rRNA depleted RNA obtained from motor neuron lines generated from subject induced pluripotent stem cell (iPSC) lines. The iPSC lines were derived from 11 ALS and 4 Control (unaffected) individuals, in duplicate.

2017-10-13 | LDS-1499 | LINCS

L1000 MCF10A Deep Dive Dataset: treatment with ligands

Project description: Not available

2021-01-20 | LDS-1603 | LINCS

RNA-seq MCF10A Deep Dive Dataset: treatment with ligands

Project description: Not available

2021-01-20 | LDS-1558 | LINCS